NOX provides update to Nyrada Note Holders  
    December 18 Nyrada Update  
    Noxopharm Releases Report on Key Progress of Subsidiary Nyrada  
    Noxopharm Subsidiary Nyrada Announces Important Drug Discovery  
    AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough  
    Nyrada- key progress with cholesterol-lowering drug candidate  
    Nyrada, Inc. Newsletter 2. April 2018  
    Nyrada,Inc. Newsletter 1. Jan/Feb 2018  
    Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.  
    Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.  
    US biotech to develop Australian science